Latest news from the Institute of Inflammation and Ageing Back to 'Institute of Inflammation and Ageing' Latest news from the Institute of Inflammation and Ageing Latest research finds hypertension drug could be repurposed to delay ageing Description:Latest research has found that rilmenidine, a drug used to treat hypertension, can be used to slow ageing and extend lifespan.Date:24 January 2023 University of Birmingham healthy-ageing pioneer awarded CBE Description:Pioneering University of Birmingham immunity expert Professor Janet Lord has been awarded a CBE in the 2023 New Year Honours.Date:03 January 2023 Inflammation and Ageing Research Fellow receives £1.2M Competitive MRC Career Development Fellowship Description:Dr Jon Hazeldine, Research Fellow at the University of Birmingham, has been awarded a competitive MRC Career Development Award Fellowship totalling £1.2M.Date:16 November 2022 Historic concussion monitoring collaboration extended during Women’s 2021 Rugby World Cup Description:The collaboration between University of Birmingham spin-off Marker Diagnostics, Rugby Football Union and World Rugby extended for the Women’s Rugby World CupDate:11 November 2022 First Midlands research collaboration to focus on patient safety Description:National Institute for Health and Care Research will establish Patient Safety Research Collaboration based in the MidlandsDate:14 October 2022 New £30M research injection to improve treatment of inflammatory diseases Description:Renewed National Institute for Health and Care Research Birmingham Biomedical Research Centre continue funds for developments around inflammatory diseasesDate:14 October 2022 Half of mild brain injury patients not recovering after six months, new commission warns Description:Report published in Lancet Neurology highlights progress and unmet needs for traumatic brain injury prevention, care, and researchDate:30 September 2022 Public support needed to tackle racial and other biases in AI for healthcare Description:Members of the public are being asked to help remove biases based on race and other disadvantaged groups in artificial intelligence algorithms for healthcareDate:26 September 2022 Research identifies new treatment target for CNS injury and neurological disease Description:Potential target could treat long-term neurological conditions like Alzheimer’s Disease and foster nerve regeneration in central nervous system injuries. Date:20 September 2022 Professor of Metabolism and Inflammation awarded £828K British Heart Foundation Research Fellowship Description:Professor Claudio Mauro has been awarded a British Heart Foundation Senior Research Fellowship towards research in immunometabolism in atherosclerosis.Date:16 September 2022 How the immune system tolerates friendly gut bacteria Description:New understanding about how the gut balances between 'good' and 'bad' bacteria could provide new clues for managing chronic gut diseasesDate:07 September 2022 Patient preferences surveyed to inform the development of acceptable new treatments Description:Study part of new European recommendations for bringing patient preferences into drug developmentDate:06 September 2022 Previous12345Next